| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An Evidence Framework for Off-Patent Pharmaceutical Review for Health Technology Assessment in Emerging Markets
|
Brixner, Diana
|
|
2018
|
16 |
C |
p. 9-13
|
artikel
|
| 2 |
Antirheumatic Medicine Prescribing Patterns and Direct Medicine Costs in the South African Private Health Sector
|
Olivier, Nericke
|
|
2018
|
16 |
C |
p. 99-105
|
artikel
|
| 3 |
Comparing Use of Health Technology Assessment in Pharmaceutical Policy among Earlier and More Recent Adopters in the European Union
|
Beletsi, Alexandra
|
|
2018
|
16 |
C |
p. 81-91
|
artikel
|
| 4 |
Copyright/Subscription
|
|
|
2018
|
16 |
C |
p. iii
|
artikel
|
| 5 |
Cost-Effectiveness of Dolutegravir as a First-Line Treatment Option in the HIV-1–Infected Treatment-Naive Patients in Russia
|
Tremblay, Gabriel
|
|
2018
|
16 |
C |
p. 74-80
|
artikel
|
| 6 |
Drug Policy in Estonia
|
Mägi, Kadri
|
|
2018
|
16 |
C |
p. 1-4
|
artikel
|
| 7 |
Drug Policy in Greece
|
Yfantopoulos, John N.
|
|
2018
|
16 |
C |
p. 66-73
|
artikel
|
| 8 |
Drug Policy in Romania
|
Radu, Ciprian-Paul
|
|
2018
|
16 |
C |
p. 28-32
|
artikel
|
| 9 |
Drug Policy in the Russian Federation
|
Holownia-Voloskova, Malwina
|
|
2018
|
16 |
C |
p. 106-111
|
artikel
|
| 10 |
Drug Policy Research and Health Technology Assessment in Central and Eastern Europe, Western Asia, and Africa: The Interface Between Research Evidence, Policy, and Practice
|
Awaisu, Ahmed
|
|
2018
|
16 |
C |
p. 119-120
|
artikel
|
| 11 |
Editorial Board
|
|
|
2018
|
16 |
C |
p. IFC
|
artikel
|
| 12 |
Highly Innovative Drug Program in the Czech Republic: Description and Pharmacoeconomic Results—Cost-Effectiveness and Budget Impact Analyses
|
Ornstova, Eva
|
|
2018
|
16 |
C |
p. 92-98
|
artikel
|
| 13 |
Indacaterol/Glycopyrronium versus Salmeterol/Fluticasone in Patients with COPD—A Cost-Effectiveness Analysis in the Czech Republic
|
Skoupa, Jana
|
|
2018
|
16 |
C |
p. 112-118
|
artikel
|
| 14 |
Managed Entry Agreements for Pharmaceutical Products in Middle East and North African Countries: Payer and Manufacturer Experience and Outlook
|
Maskineh, Christiane
|
|
2018
|
16 |
C |
p. 33-38
|
artikel
|
| 15 |
Optimization Approach for Estimating the Required Amount of Pharmaceuticals in the Russian Federation
|
Prasolov, A.V.
|
|
2018
|
16 |
C |
p. 39-45
|
artikel
|
| 16 |
Pharmacoeconomics Evaluations of Oral Anticancer Agents: Systematic Review of Characteristics, Methodological Trends, and Reporting Quality
|
Al Kadour, Ahmad
|
|
2018
|
16 |
C |
p. 46-60
|
artikel
|
| 17 |
Return on Investment Analysis of Breast Cancer Screening and Downstaging in Egypt: Implications for Developing Countries
|
Skrundevskiy, Alena N.
|
|
2018
|
16 |
C |
p. 22-27
|
artikel
|
| 18 |
Smoking Behavior among Jordanians: Physical, Psychological, Social, and Economic Reasons
|
Sweis, Nadia J.
|
|
2018
|
16 |
C |
p. 5-8
|
artikel
|
| 19 |
Table of Contents
|
|
|
2018
|
16 |
C |
p. i-ii
|
artikel
|
| 20 |
The State of Health Technology Assessment in the Ethiopian Health Sector: Learning from Recent Policy Initiatives
|
Zegeye, Elias Asfaw
|
|
2018
|
16 |
C |
p. 61-65
|
artikel
|
| 21 |
Treatment Satisfaction Questionnaire for Medication: Validation of the Translated Arabic Version among Patients Undergoing Warfarin Therapy in Saudi Arabia
|
Shilbayeh, Sireen Abdul Rahim
|
|
2018
|
16 |
C |
p. 14-21
|
artikel
|
Tijdschrift beschrijving